 | • レポートコード：MRC2-11QY01421 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はヒト凝固因子IVのグローバル市場について調査・分析したレポートです。種類別（カルシウムイオン、カルシウム化合物）市場規模、用途別（病院、パーソナルクリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヒト凝固因子IVの競争状況、市場シェア ・世界のヒト凝固因子IV市場：種類別市場規模 2015年-2020年（カルシウムイオン、カルシウム化合物） ・世界のヒト凝固因子IV市場：種類別市場規模予測 2021年-2026年（カルシウムイオン、カルシウム化合物） ・世界のヒト凝固因子IV市場：用途別市場規模 2015年-2020年（病院、パーソナルクリニック、その他） ・世界のヒト凝固因子IV市場：用途別市場規模予測 2021年-2026年（病院、パーソナルクリニック、その他） ・北米のヒト凝固因子IV市場分析：米国、カナダ ・ヨーロッパのヒト凝固因子IV市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのヒト凝固因子IV市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のヒト凝固因子IV市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのヒト凝固因子IV市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Baxter、Bayer、CSL、Pfizer、Grifols、Biogen、Octapharma、Novo Nordisk、Greencross、Kedrion、BPL、Hualan Bio、RAAS ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Human Coagulation Factor IV Market
The global Human Coagulation Factor IV market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Human Coagulation Factor IV Scope and Market Size
Human Coagulation Factor IV market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Coagulation Factor IV market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Human Coagulation Factor IV market is segmented into
Calcium Ion
Calcium Compounds
Segment by Application, the Human Coagulation Factor IV market is segmented into
Hospital
Personal Clinic
Others
Regional and Country-level Analysis
The Human Coagulation Factor IV market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Coagulation Factor IV market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Coagulation Factor IV Market Share Analysis
Human Coagulation Factor IV market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Coagulation Factor IV business, the date to enter into the Human Coagulation Factor IV market, Human Coagulation Factor IV product introduction, recent developments, etc.
The major vendors covered:
Baxter
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
Novo Nordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
1 Study Coverage
1.1 Human Coagulation Factor IV Product Introduction
1.2 Market Segments
1.3 Key Human Coagulation Factor IV Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Coagulation Factor IV Market Size Growth Rate by Type
1.4.2 Calcium Ion
1.4.3 Calcium Compounds
1.5 Market by Application
1.5.1 Global Human Coagulation Factor IV Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Personal Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Coagulation Factor IV Market Size, Estimates and Forecasts
2.1.1 Global Human Coagulation Factor IV Revenue 2015-2026
2.1.2 Global Human Coagulation Factor IV Sales 2015-2026
2.2 Global Human Coagulation Factor IV, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human Coagulation Factor IV Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Coagulation Factor IV Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Coagulation Factor IV Competitor Landscape by Players
3.1 Human Coagulation Factor IV Sales by Manufacturers
3.1.1 Human Coagulation Factor IV Sales by Manufacturers (2015-2020)
3.1.2 Human Coagulation Factor IV Sales Market Share by Manufacturers (2015-2020)
3.2 Human Coagulation Factor IV Revenue by Manufacturers
3.2.1 Human Coagulation Factor IV Revenue by Manufacturers (2015-2020)
3.2.2 Human Coagulation Factor IV Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Coagulation Factor IV Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Coagulation Factor IV Revenue in 2019
3.2.5 Global Human Coagulation Factor IV Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Coagulation Factor IV Price by Manufacturers
3.4 Human Coagulation Factor IV Manufacturing Base Distribution, Product Types
3.4.1 Human Coagulation Factor IV Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Coagulation Factor IV Product Type
3.4.3 Date of International Manufacturers Enter into Human Coagulation Factor IV Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Coagulation Factor IV Market Size by Type (2015-2020)
4.1.1 Global Human Coagulation Factor IV Sales by Type (2015-2020)
4.1.2 Global Human Coagulation Factor IV Revenue by Type (2015-2020)
4.1.3 Human Coagulation Factor IV Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Coagulation Factor IV Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Coagulation Factor IV Sales Forecast by Type (2021-2026)
4.2.2 Global Human Coagulation Factor IV Revenue Forecast by Type (2021-2026)
4.2.3 Human Coagulation Factor IV Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Coagulation Factor IV Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Human Coagulation Factor IV Market Size by Application (2015-2020)
5.1.1 Global Human Coagulation Factor IV Sales by Application (2015-2020)
5.1.2 Global Human Coagulation Factor IV Revenue by Application (2015-2020)
5.1.3 Human Coagulation Factor IV Price by Application (2015-2020)
5.2 Human Coagulation Factor IV Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Coagulation Factor IV Sales Forecast by Application (2021-2026)
5.2.2 Global Human Coagulation Factor IV Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Coagulation Factor IV Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human Coagulation Factor IV by Country
6.1.1 North America Human Coagulation Factor IV Sales by Country
6.1.2 North America Human Coagulation Factor IV Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Coagulation Factor IV Market Facts & Figures by Type
6.3 North America Human Coagulation Factor IV Market Facts & Figures by Application
7 Europe
7.1 Europe Human Coagulation Factor IV by Country
7.1.1 Europe Human Coagulation Factor IV Sales by Country
7.1.2 Europe Human Coagulation Factor IV Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Coagulation Factor IV Market Facts & Figures by Type
7.3 Europe Human Coagulation Factor IV Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Human Coagulation Factor IV by Region
8.1.1 Asia Pacific Human Coagulation Factor IV Sales by Region
8.1.2 Asia Pacific Human Coagulation Factor IV Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Coagulation Factor IV Market Facts & Figures by Type
8.3 Asia Pacific Human Coagulation Factor IV Market Facts & Figures by Application
9 Latin America
9.1 Latin America Human Coagulation Factor IV by Country
9.1.1 Latin America Human Coagulation Factor IV Sales by Country
9.1.2 Latin America Human Coagulation Factor IV Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Coagulation Factor IV Market Facts & Figures by Type
9.3 Central & South America Human Coagulation Factor IV Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Human Coagulation Factor IV by Country
10.1.1 Middle East and Africa Human Coagulation Factor IV Sales by Country
10.1.2 Middle East and Africa Human Coagulation Factor IV Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Coagulation Factor IV Market Facts & Figures by Type
10.3 Middle East and Africa Human Coagulation Factor IV Market Facts & Figures by Application
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description and Business Overview
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Human Coagulation Factor IV Products Offered
11.1.5 Baxter Related Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Description and Business Overview
11.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer Human Coagulation Factor IV Products Offered
11.2.5 Bayer Related Developments
11.3 CSL
11.3.1 CSL Corporation Information
11.3.2 CSL Description and Business Overview
11.3.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CSL Human Coagulation Factor IV Products Offered
11.3.5 CSL Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Human Coagulation Factor IV Products Offered
11.4.5 Pfizer Related Developments
11.5 Grifols
11.5.1 Grifols Corporation Information
11.5.2 Grifols Description and Business Overview
11.5.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Grifols Human Coagulation Factor IV Products Offered
11.5.5 Grifols Related Developments
11.6 Biogen
11.6.1 Biogen Corporation Information
11.6.2 Biogen Description and Business Overview
11.6.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Biogen Human Coagulation Factor IV Products Offered
11.6.5 Biogen Related Developments
11.7 Octapharma
11.7.1 Octapharma Corporation Information
11.7.2 Octapharma Description and Business Overview
11.7.3 Octapharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Octapharma Human Coagulation Factor IV Products Offered
11.7.5 Octapharma Related Developments
11.8 Novo Nordisk
11.8.1 Novo Nordisk Corporation Information
11.8.2 Novo Nordisk Description and Business Overview
11.8.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novo Nordisk Human Coagulation Factor IV Products Offered
11.8.5 Novo Nordisk Related Developments
11.9 Greencross
11.9.1 Greencross Corporation Information
11.9.2 Greencross Description and Business Overview
11.9.3 Greencross Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Greencross Human Coagulation Factor IV Products Offered
11.9.5 Greencross Related Developments
11.10 Kedrion
11.10.1 Kedrion Corporation Information
11.10.2 Kedrion Description and Business Overview
11.10.3 Kedrion Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Kedrion Human Coagulation Factor IV Products Offered
11.10.5 Kedrion Related Developments
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description and Business Overview
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Human Coagulation Factor IV Products Offered
11.1.5 Baxter Related Developments
11.12 Hualan Bio
11.12.1 Hualan Bio Corporation Information
11.12.2 Hualan Bio Description and Business Overview
11.12.3 Hualan Bio Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Hualan Bio Products Offered
11.12.5 Hualan Bio Related Developments
11.13 RAAS
11.13.1 RAAS Corporation Information
11.13.2 RAAS Description and Business Overview
11.13.3 RAAS Sales, Revenue and Gross Margin (2015-2020)
11.13.4 RAAS Products Offered
11.13.5 RAAS Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Coagulation Factor IV Market Estimates and Projections by Region
12.1.1 Global Human Coagulation Factor IV Sales Forecast by Regions 2021-2026
12.1.2 Global Human Coagulation Factor IV Revenue Forecast by Regions 2021-2026
12.2 North America Human Coagulation Factor IV Market Size Forecast (2021-2026)
12.2.1 North America: Human Coagulation Factor IV Sales Forecast (2021-2026)
12.2.2 North America: Human Coagulation Factor IV Revenue Forecast (2021-2026)
12.2.3 North America: Human Coagulation Factor IV Market Size Forecast by Country (2021-2026)
12.3 Europe Human Coagulation Factor IV Market Size Forecast (2021-2026)
12.3.1 Europe: Human Coagulation Factor IV Sales Forecast (2021-2026)
12.3.2 Europe: Human Coagulation Factor IV Revenue Forecast (2021-2026)
12.3.3 Europe: Human Coagulation Factor IV Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Coagulation Factor IV Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Coagulation Factor IV Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Coagulation Factor IV Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Coagulation Factor IV Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Coagulation Factor IV Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Coagulation Factor IV Sales Forecast (2021-2026)
12.5.2 Latin America: Human Coagulation Factor IV Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Coagulation Factor IV Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Coagulation Factor IV Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Coagulation Factor IV Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Coagulation Factor IV Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Coagulation Factor IV Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Human Coagulation Factor IV Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Coagulation Factor IV Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Human Coagulation Factor IV Market Segments
Table 2. Ranking of Global Top Human Coagulation Factor IV Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Coagulation Factor IV Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Calcium Ion
Table 5. Major Manufacturers of Calcium Compounds
Table 6. Global Human Coagulation Factor IV Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 7. Global Human Coagulation Factor IV Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 8. Global Human Coagulation Factor IV Sales by Regions 2015-2020 (K Pcs)
Table 9. Global Human Coagulation Factor IV Sales Market Share by Regions (2015-2020)
Table 10. Global Human Coagulation Factor IV Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Human Coagulation Factor IV Sales by Manufacturers (2015-2020) (K Pcs)
Table 12. Global Human Coagulation Factor IV Sales Share by Manufacturers (2015-2020)
Table 13. Global Human Coagulation Factor IV Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Human Coagulation Factor IV by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Coagulation Factor IV as of 2019)
Table 15. Human Coagulation Factor IV Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Human Coagulation Factor IV Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Human Coagulation Factor IV Price (2015-2020) (USD/Pcs)
Table 18. Human Coagulation Factor IV Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Human Coagulation Factor IV Product Type
Table 20. Date of International Manufacturers Enter into Human Coagulation Factor IV Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Human Coagulation Factor IV Sales by Type (2015-2020) (K Pcs)
Table 23. Global Human Coagulation Factor IV Sales Share by Type (2015-2020)
Table 24. Global Human Coagulation Factor IV Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Human Coagulation Factor IV Revenue Share by Type (2015-2020)
Table 26. Human Coagulation Factor IV Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 27. Global Human Coagulation Factor IV Sales by Application (2015-2020) (K Pcs)
Table 28. Global Human Coagulation Factor IV Sales Share by Application (2015-2020)
Table 29. North America Human Coagulation Factor IV Sales by Country (2015-2020) (K Pcs)
Table 30. North America Human Coagulation Factor IV Sales Market Share by Country (2015-2020)
Table 31. North America Human Coagulation Factor IV Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Human Coagulation Factor IV Revenue Market Share by Country (2015-2020)
Table 33. North America Human Coagulation Factor IV Sales by Type (2015-2020) (K Pcs)
Table 34. North America Human Coagulation Factor IV Sales Market Share by Type (2015-2020)
Table 35. North America Human Coagulation Factor IV Sales by Application (2015-2020) (K Pcs)
Table 36. North America Human Coagulation Factor IV Sales Market Share by Application (2015-2020)
Table 37. Europe Human Coagulation Factor IV Sales by Country (2015-2020) (K Pcs)
Table 38. Europe Human Coagulation Factor IV Sales Market Share by Country (2015-2020)
Table 39. Europe Human Coagulation Factor IV Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Human Coagulation Factor IV Revenue Market Share by Country (2015-2020)
Table 41. Europe Human Coagulation Factor IV Sales by Type (2015-2020) (K Pcs)
Table 42. Europe Human Coagulation Factor IV Sales Market Share by Type (2015-2020)
Table 43. Europe Human Coagulation Factor IV Sales by Application (2015-2020) (K Pcs)
Table 44. Europe Human Coagulation Factor IV Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Human Coagulation Factor IV Sales by Region (2015-2020) (K Pcs)
Table 46. Asia Pacific Human Coagulation Factor IV Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Human Coagulation Factor IV Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Human Coagulation Factor IV Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Human Coagulation Factor IV Sales by Type (2015-2020) (K Pcs)
Table 50. Asia Pacific Human Coagulation Factor IV Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Human Coagulation Factor IV Sales by Application (2015-2020) (K Pcs)
Table 52. Asia Pacific Human Coagulation Factor IV Sales Market Share by Application (2015-2020)
Table 53. Latin America Human Coagulation Factor IV Sales by Country (2015-2020) (K Pcs)
Table 54. Latin America Human Coagulation Factor IV Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Human Coagulation Factor IV Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Human Coagulation Factor IV Revenue Market Share by Country (2015-2020)
Table 57. Latin America Human Coagulation Factor IV Sales by Type (2015-2020) (K Pcs)
Table 58. Latin America Human Coagulation Factor IV Sales Market Share by Type (2015-2020)
Table 59. Latin America Human Coagulation Factor IV Sales by Application (2015-2020) (K Pcs)
Table 60. Latin America Human Coagulation Factor IV Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Human Coagulation Factor IV Sales by Country (2015-2020) (K Pcs)
Table 62. Middle East and Africa Human Coagulation Factor IV Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Human Coagulation Factor IV Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Human Coagulation Factor IV Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Human Coagulation Factor IV Sales by Type (2015-2020) (K Pcs)
Table 66. Middle East and Africa Human Coagulation Factor IV Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Human Coagulation Factor IV Sales by Application (2015-2020) (K Pcs)
Table 68. Middle East and Africa Human Coagulation Factor IV Sales Market Share by Application (2015-2020)
Table 69. Baxter Corporation Information
Table 70. Baxter Description and Major Businesses
Table 71. Baxter Human Coagulation Factor IV Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 72. Baxter Product
Table 73. Baxter Recent Development
Table 74. Bayer Corporation Information
Table 75. Bayer Description and Major Businesses
Table 76. Bayer Human Coagulation Factor IV Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Bayer Product
Table 78. Bayer Recent Development
Table 79. CSL Corporation Information
Table 80. CSL Description and Major Businesses
Table 81. CSL Human Coagulation Factor IV Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. CSL Product
Table 83. CSL Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Major Businesses
Table 86. Pfizer Human Coagulation Factor IV Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. Grifols Corporation Information
Table 90. Grifols Description and Major Businesses
Table 91. Grifols Human Coagulation Factor IV Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Grifols Product
Table 93. Grifols Recent Development
Table 94. Biogen Corporation Information
Table 95. Biogen Description and Major Businesses
Table 96. Biogen Human Coagulation Factor IV Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Biogen Product
Table 98. Biogen Recent Development
Table 99. Octapharma Corporation Information
Table 100. Octapharma Description and Major Businesses
Table 101. Octapharma Human Coagulation Factor IV Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Octapharma Product
Table 103. Octapharma Recent Development
Table 104. Novo Nordisk Corporation Information
Table 105. Novo Nordisk Description and Major Businesses
Table 106. Novo Nordisk Human Coagulation Factor IV Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Novo Nordisk Product
Table 108. Novo Nordisk Recent Development
Table 109. Greencross Corporation Information
Table 110. Greencross Description and Major Businesses
Table 111. Greencross Human Coagulation Factor IV Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Greencross Product
Table 113. Greencross Recent Development
Table 114. Kedrion Corporation Information
Table 115. Kedrion Description and Major Businesses
Table 116. Kedrion Human Coagulation Factor IV Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Kedrion Product
Table 118. Kedrion Recent Development
Table 119. BPL Corporation Information
Table 120. BPL Description and Major Businesses
Table 121. BPL Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. BPL Product
Table 123. BPL Recent Development
Table 124. Hualan Bio Corporation Information
Table 125. Hualan Bio Description and Major Businesses
Table 126. Hualan Bio Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. Hualan Bio Product
Table 128. Hualan Bio Recent Development
Table 129. RAAS Corporation Information
Table 130. RAAS Description and Major Businesses
Table 131. RAAS Human Coagulation Factor IV Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. RAAS Product
Table 133. RAAS Recent Development
Table 134. Global Human Coagulation Factor IV Sales Forecast by Regions (2021-2026) (K Pcs)
Table 135. Global Human Coagulation Factor IV Sales Market Share Forecast by Regions (2021-2026)
Table 136. Global Human Coagulation Factor IV Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 137. Global Human Coagulation Factor IV Revenue Market Share Forecast by Regions (2021-2026)
Table 138. North America: Human Coagulation Factor IV Sales Forecast by Country (2021-2026) (K Pcs)
Table 139. North America: Human Coagulation Factor IV Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Europe: Human Coagulation Factor IV Sales Forecast by Country (2021-2026) (K Pcs)
Table 141. Europe: Human Coagulation Factor IV Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Asia Pacific: Human Coagulation Factor IV Sales Forecast by Region (2021-2026) (K Pcs)
Table 143. Asia Pacific: Human Coagulation Factor IV Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Latin America: Human Coagulation Factor IV Sales Forecast by Country (2021-2026) (K Pcs)
Table 145. Latin America: Human Coagulation Factor IV Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Middle East and Africa: Human Coagulation Factor IV Sales Forecast by Country (2021-2026) (K Pcs)
Table 147. Middle East and Africa: Human Coagulation Factor IV Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Market Risks
Table 151. Main Points Interviewed from Key Human Coagulation Factor IV Players
Table 152. Human Coagulation Factor IV Customers List
Table 153. Human Coagulation Factor IV Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor IV Product Picture
Figure 2. Global Human Coagulation Factor IV Sales Market Share by Type in 2020 & 2026
Figure 3. Calcium Ion Product Picture
Figure 4. Calcium Compounds Product Picture
Figure 5. Global Human Coagulation Factor IV Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Personal Clinic
Figure 8. Others
Figure 9. Human Coagulation Factor IV Report Years Considered
Figure 10. Global Human Coagulation Factor IV Market Size 2015-2026 (US$ Million)
Figure 11. Global Human Coagulation Factor IV Sales 2015-2026 (K Pcs)
Figure 12. Global Human Coagulation Factor IV Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Human Coagulation Factor IV Sales Market Share by Region (2015-2020)
Figure 14. Global Human Coagulation Factor IV Sales Market Share by Region in 2019
Figure 15. Global Human Coagulation Factor IV Revenue Market Share by Region (2015-2020)
Figure 16. Global Human Coagulation Factor IV Revenue Market Share by Region in 2019
Figure 17. Global Human Coagulation Factor IV Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Human Coagulation Factor IV Revenue in 2019
Figure 19. Human Coagulation Factor IV Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Human Coagulation Factor IV Sales Market Share by Type (2015-2020)
Figure 21. Global Human Coagulation Factor IV Sales Market Share by Type in 2019
Figure 22. Global Human Coagulation Factor IV Revenue Market Share by Type (2015-2020)
Figure 23. Global Human Coagulation Factor IV Revenue Market Share by Type in 2019
Figure 24. Global Human Coagulation Factor IV Market Share by Price Range (2015-2020)
Figure 25. Global Human Coagulation Factor IV Sales Market Share by Application (2015-2020)
Figure 26. Global Human Coagulation Factor IV Sales Market Share by Application in 2019
Figure 27. Global Human Coagulation Factor IV Revenue Market Share by Application (2015-2020)
Figure 28. Global Human Coagulation Factor IV Revenue Market Share by Application in 2019
Figure 29. North America Human Coagulation Factor IV Sales Growth Rate 2015-2020 (K Pcs)
Figure 30. North America Human Coagulation Factor IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Human Coagulation Factor IV Sales Market Share by Country in 2019
Figure 32. North America Human Coagulation Factor IV Revenue Market Share by Country in 2019
Figure 33. U.S. Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 34. U.S. Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. Canada Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Human Coagulation Factor IV Market Share by Type in 2019
Figure 38. North America Human Coagulation Factor IV Market Share by Application in 2019
Figure 39. Europe Human Coagulation Factor IV Sales Growth Rate 2015-2020 (K Pcs)
Figure 40. Europe Human Coagulation Factor IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Human Coagulation Factor IV Sales Market Share by Country in 2019
Figure 42. Europe Human Coagulation Factor IV Revenue Market Share by Country in 2019
Figure 43. Germany Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Germany Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. France Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. U.K. Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Italy Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Russia Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Human Coagulation Factor IV Market Share by Type in 2019
Figure 54. Europe Human Coagulation Factor IV Market Share by Application in 2019
Figure 55. Asia Pacific Human Coagulation Factor IV Sales Growth Rate 2015-2020 (K Pcs)
Figure 56. Asia Pacific Human Coagulation Factor IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Human Coagulation Factor IV Sales Market Share by Region in 2019
Figure 58. Asia Pacific Human Coagulation Factor IV Revenue Market Share by Region in 2019
Figure 59. China Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. China Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Japan Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. South Korea Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. India Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Australia Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Taiwan Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Indonesia Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Thailand Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Malaysia Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Philippines Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Vietnam Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Human Coagulation Factor IV Market Share by Type in 2019
Figure 82. Asia Pacific Human Coagulation Factor IV Market Share by Application in 2019
Figure 83. Latin America Human Coagulation Factor IV Sales Growth Rate 2015-2020 (K Pcs)
Figure 84. Latin America Human Coagulation Factor IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Human Coagulation Factor IV Sales Market Share by Country in 2019
Figure 86. Latin America Human Coagulation Factor IV Revenue Market Share by Country in 2019
Figure 87. Mexico Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Mexico Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Brazil Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Argentina Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Human Coagulation Factor IV Market Share by Type in 2019
Figure 94. Latin America Human Coagulation Factor IV Market Share by Application in 2019
Figure 95. Middle East and Africa Human Coagulation Factor IV Sales Growth Rate 2015-2020 (K Pcs)
Figure 96. Middle East and Africa Human Coagulation Factor IV Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Human Coagulation Factor IV Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Human Coagulation Factor IV Revenue Market Share by Country in 2019
Figure 99. Turkey Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 100. Turkey Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Saudi Arabia Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Human Coagulation Factor IV Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. U.A.E Human Coagulation Factor IV Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Human Coagulation Factor IV Market Share by Type in 2019
Figure 106. Middle East and Africa Human Coagulation Factor IV Market Share by Application in 2019
Figure 107. North America Human Coagulation Factor IV Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 108. North America Human Coagulation Factor IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Human Coagulation Factor IV Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. Europe Human Coagulation Factor IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Human Coagulation Factor IV Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Asia Pacific Human Coagulation Factor IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Human Coagulation Factor IV Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Latin America Human Coagulation Factor IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Human Coagulation Factor IV Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Middle East and Africa Human Coagulation Factor IV Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
ヒト凝固因子IXの世界市場（～2026年） Market Analysis and Insights: Global Human Coagulation Factor IX Market The global Human Coagulation Factor IX market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Coagulation Factor IX Scope and Market Size Human Coa…- 凝固XI因子の世界市場（～2026年） Market Analysis and Insights: Global Coagulation Factor XI Market The global Coagulation Factor XI market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Coagulation Factor XI Scope and Market Size Coagulation Factor XI marke…
- 凝固因子濃縮物の世界市場（～2026年） Market Analysis and Insights: Global Coagulation Factor Concentrates Market The global Coagulation Factor Concentrates market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Coagulation Factor Concentrates Scope and Market Si…
- 組換え凝固因子の世界市場（～2026年） Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents. Market Analysis and Insights: Global Recomb…
- 分散型/ POC凝固検査の世界市場（～2026年） Cardiovascular diseases present a wide range of blood disorders (haemostasis) that influences the development cardiovascular co morbidities. Patients exhibiting such symptoms are often prescribed on anti-thrombotic medications to prevent the onset of adverse cardiovascular events arising as a result…